Filter By Industry
Filter By Tag

Newsroom

Nova Biomedical Press releases

1 - 10 of 20 Press Releases

Oct 02, 2023
Biomedical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for a micro capillary sample mode on the Stat Profile Prime Plus® Critical Care analyzer.

Jan 04, 2023
Nova Biomedical is pleased to announce the launch of BioProfile FAST CDV, a high-throughput, fully automated viable cell density and viability analyzer capable of producing results in under 70 seconds with just 100μL of sample volume.

Oct 28, 2022
The U.S. Food and Drug Administration (FDA) has cleared Nova Primary as a blood glucose reference analyzer.

Mar 09, 2022
Nova Biomedical announces the launch of the Nova Max Pro Creatinine/eGFR Meter System in all CE countries.

May 10, 2021
In a 670-patient study funded by the International Society of Nephrology, the South Africa Medical Research Council, and the University of Witwatersrand, Johannesburg, South Africa, the Nova POC StatSensor Creatinine/eGFR meter was more accurate than the.

Apr 30, 2021
Nova Biomedical is pleased to announce the opening of a new sales, service, and distribution subsidiary in Benelux.

Jan 22, 2021
Nova Biomedical announces the addition of a Sample Retain Collector (SRC) for BioProfile FLEX2 cell culture analyzer.

Nov 10, 2020
Nova Biomedical announces the availability of Nova Primary, a rapid, accurate, easy to use, blood glucose laboratory analyzer.

Oct 07, 2020
Nova Biomedical announces the addition of C-reactive protein (CRP) testing to its Allegro capillary blood analyzer for point-of-care (POC) testing in primary care settings.

Apr 17, 2020
Risk of Ascorbic Acid and Hematocrit Interference That Can Elevate Glucose Meter Results


Page: 1 2 Next
Nova Biomedical RSS Feed